(1) Background: Numerous vaccines are under preclinical and clinical development for
prevention of severe course and lethal outcome of coronavirus disease 2019 (COVID-19). In …

COVID-19 is an infectious disease caused by a single-stranded RNA (ssRNA) virus, known
as SARS-CoV-2. The disease, since its first outbreak in Wuhan, China, in December 2019 …

Background Currently there is no systematic review and meta-analysis of the global
incidence rates of anaphylactic and nonanaphylactic reactions to SARS-CoV-2 vaccines in …

Vaccinationis a critical tool in the prevention of COVID‐19 infection for individuals and for
communities. The mRNA vaccines contain polyethylene glycol (PEG) as a stabilizer …

Presently, the whole globe is struggling the tough challenge of the COVID-19 pandemic.
Vaccination remains the most effective and safe COVID-19 weapon for adults and in the …

Introduction Since its emergence, there have been huge efforts to design vaccines against
coronavirus disease 2019 (COVID-19) to inhibit its interpersonal spread. Global vaccine …

Objectives In this study covering all of Turkey, we aimed to define cutaneous and systemic
adverse reactions in our patient population after COVID‐19 vaccination with the …

Background In December 2020, the Israeli Ministry of Health launched a national
vaccination campaign against SARS-CoV-2. Concomitant sporadic reports on anaphylactic …

Abstract The SARS-CoV-2 Virus (COVID-19) is responsible for over 239 million cases and
4.8 million deaths globally (Data source WHO COVID-19 Dashboard accessed on October …

Background The rapid development and rollout of vaccines against coronavirus disease
2019 (COVID-19) has led to more than half of the world's population being vaccinated to …